Stock 6712 EVER SUPREME BIO TECHNOLOGY CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ever Supreme Bio Technology Co., Ltd

Equities

6712

TW0006712003

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 25/04/2024 BST 		5-day change 1st Jan Change
207 TWD -2.13% Intraday chart for Ever Supreme Bio Technology Co., Ltd +3.50% +5.88%
03-29 Ever Supreme Bio Technology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-15 Ever Supreme Bio Technology Co., Ltd Announces to Distribute Dividends for the Period January 1, 2023 to December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 5,656 9,043 9,856 13,013 15,025 14,338
Enterprise Value (EV) 1 4,858 8,485 9,484 11,703 13,773 13,009
P/E ratio -77.1 x -96 x -92.1 x 35.4 x 75.3 x 27.1 x
Yield - - - 2.38% 0.9% 1.79%
Capitalization / Revenue - 835,885,008 x 139,609,331 x 29,652,400 x 23,943,663 x 18,905,448 x
EV / Revenue - 784,288,835 x 134,343,230 x 26,668,891 x 21,948,957 x 17,152,867 x
EV / EBITDA -55.7 x -68.8 x -69.9 x 82.7 x 44.8 x 36.4 x
EV / FCF -70.7 x -100 x -64 x 117 x 62.7 x 42.7 x
FCF Yield -1.41% -1% -1.56% 0.86% 1.59% 2.34%
Price to Book 6.07 x 10.7 x 12.7 x 6.86 x 8.38 x 7.78 x
Nbr of stocks (in thousands) 67,738 67,738 67,738 74,776 74,931 73,339
Reference price 2 83.50 133.5 145.5 174.0 200.5 195.5
Announcement Date 30/04/19 27/04/20 26/03/21 28/03/22 30/03/23 29/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - 10.82 70.6 438.8 627.5 758.4
EBITDA 1 -87.23 -123.4 -135.6 141.5 307.3 357.7
EBIT 1 -93.77 -135.5 -157.1 116.2 283.8 337.7
Operating Margin - -1,252.31% -222.54% 26.48% 45.23% 44.53%
Earnings before Tax (EBT) 1 -87.02 -119.6 -137.4 396.8 264.1 623
Net income 1 -68.77 -94.22 -106.8 369.6 200.7 539.4
Net margin - -870.87% -151.32% 84.22% 31.99% 71.12%
EPS 2 -1.083 -1.391 -1.579 4.911 2.664 7.220
Free Cash Flow 1 -68.69 -84.78 -148.1 100.3 219.6 304.5
FCF margin - -783.66% -209.76% 22.86% 35% 40.15%
FCF Conversion (EBITDA) - - - 70.91% 71.47% 85.12%
FCF Conversion (Net income) - - - 27.14% 109.41% 56.45%
Dividend per Share - - - 4.134 1.812 3.500
Announcement Date 30/04/19 27/04/20 26/03/21 28/03/22 30/03/23 29/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales 1 143.7 155.1 123.5 152.6 - 179.7 116.9 159.7 226.8 112.3
EBITDA - - - - - - - - - -
EBIT 1 49.9 60.36 49.34 61.49 - 98.09 23.99 62.14 117.7 63.59
Operating Margin 34.73% 38.92% 39.95% 40.29% - 54.57% 20.53% 38.91% 51.89% 56.63%
Earnings before Tax (EBT) - - - - - - - - - -
Net income 1 - - - - 38.24 - - - - 98.1
Net margin - - - - - - - - - 87.36%
EPS 2 - - - - 0.5092 - - - - 1.340
Dividend per Share - - - - - - - - - -
Announcement Date 09/11/21 24/03/22 12/05/22 12/08/22 11/11/22 30/03/23 15/05/23 11/08/23 14/11/23 29/03/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 798 558 372 1,309 1,252 1,329
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -68.7 -84.8 -148 100 220 304
ROE (net income / shareholders' equity) -10.7% -10.6% -13.1% 27.6% 10.9% 29.7%
ROA (Net income/ Total Assets) -9% -9.12% -11.1% 5.04% 8.88% 10.4%
Assets 1 764 1,033 962.4 7,331 2,261 5,174
Book Value Per Share 2 13.70 12.50 11.50 25.40 23.90 25.10
Cash Flow per Share 2 0.2000 0.4700 1.010 8.570 4.720 4.590
Capex 1 20.6 5.36 58.8 1.98 3.19 5.82
Capex / Sales - 49.58% 83.33% 0.45% 0.51% 0.77%
Announcement Date 30/04/19 27/04/20 26/03/21 28/03/22 30/03/23 29/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
EVER SUPREME BIO TECHNOLOGY CO., LTD Stock Ever Supreme Bio Technology Co., Ltd
+5.88% 465M
CSL LIMITED Stock CSL Limited
-4.66% 86.13B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.32% 39.82B
BIOGEN INC. Stock Biogen Inc.
-19.27% 30.42B
UCB Stock UCB
+57.86% 25.23B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-16.09% 15.35B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.14% 11.95B
INCYTE CORPORATION Stock Incyte Corporation
-17.69% 11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.00% 11.51B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.24% 8.71B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 6712 Stock
  4. Financials Ever Supreme Bio Technology Co., Ltd